These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 4843878)

  • 21. [Preferential efficicacy of immunocomplexes in the facilitation of tumor allografts].
    Duc HT; Kinsky RG; Voisin GA
    Ann Immunol (Paris); 1973 Nov; 124(4):567-72. PubMed ID: 4134880
    [No Abstract]   [Full Text] [Related]  

  • 22. EFFECT OF THORACIC DUCT LYMPH DRAINAGE ON THE IMMUNE RESPONSE IN MAN.
    TUNNER WS; CARBONE PP; IRVING L
    Surg Gynecol Obstet; 1965 Aug; 121():334-8. PubMed ID: 14320384
    [No Abstract]   [Full Text] [Related]  

  • 23. Traffic of lymphocytes in the thoracic duct and renal lymph after allotransplantation and in immunosuppression.
    Evans CM; Blamey RW; Elston CW
    Transplantation; 1978 Dec; 26(6):382-7. PubMed ID: 366821
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanism of induction of immunological tolerance. VI. Tolerance induction following thoracic duct drainage or treatment with anti-lymphocyte serum.
    Shellam GR
    Immunology; 1969 Aug; 17(2):267-80. PubMed ID: 5804536
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection of tumor-associated transplantation antigen of BO-IV carcinoma on somatic cells of tumor-free syngeneic mice. IV. Search for this antigen on syngeneic embryonic tissues.
    Rejthar A
    Folia Biol (Praha); 1974; 20(4):252-7. PubMed ID: 4412745
    [No Abstract]   [Full Text] [Related]  

  • 26. [Lymph drainage by an external fistula of the thoracic duct].
    Reggiani A; Rusconi R
    Minerva Nefrol; 1971; 18(1):9-14. PubMed ID: 4936080
    [No Abstract]   [Full Text] [Related]  

  • 27. Lymphocyte-dependent antibody in a tumor xenograft system.
    Simpson E; Beverley PC; Jones V
    Transplant Proc; 1973 Mar; 5(1):161-6. PubMed ID: 4695940
    [No Abstract]   [Full Text] [Related]  

  • 28. The importance of dose and proliferation of SV40-transformed cells with different oncogenic potentials to the level of tumor immunity.
    Stillström J
    Int J Cancer; 1974 Mar; 13(3):273-85. PubMed ID: 4362607
    [No Abstract]   [Full Text] [Related]  

  • 29. [Cytotoxic lymphocytes and anti-tumor immunity].
    Cerottini JC; Brunner KT
    Ann Inst Pasteur (Paris); 1972 Apr; 122(4):659-68. PubMed ID: 4403239
    [No Abstract]   [Full Text] [Related]  

  • 30. [Immunologic response to transplantable specific antigens in experimental tumors].
    Porwit-Bóbr Z
    Postepy Hig Med Dosw; 1971; 25(1):25-36. PubMed ID: 4932042
    [No Abstract]   [Full Text] [Related]  

  • 31. [Biologic fundamentals and advances in kidney transplantation. IV. Immunosuppression with antilymphocytic serum and specific tolerances].
    Lawson RK; Kirchheim D
    Urologe; 1967; 6(6):359-67. PubMed ID: 4873352
    [No Abstract]   [Full Text] [Related]  

  • 32. The effect of thoracic duct lymph drainage in myasthenia gravis.
    Bergström K; Franksson C; Matell G; von Reis G
    Eur Neurol; 1973; 9(3):157-67. PubMed ID: 4347852
    [No Abstract]   [Full Text] [Related]  

  • 33. In vitro studies on the cellular immune response of tumor-bearing mice to SV40-transformed cells.
    Blasecki JW; Tevethia SS
    J Immunol; 1975 Jan; 114(1 Pt 1):244-9. PubMed ID: 163278
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recovery of immune responsiveness after cessation of thoracic duct drainage in calves and man.
    Graber CD; Fitts CT; Williams AV; Artz CP; Othersen HB
    Ann Surg; 1970 Feb; 171(2):241-9. PubMed ID: 4905128
    [No Abstract]   [Full Text] [Related]  

  • 35. [Specific growth rate and macrophagal infiltration of experimental tumors].
    Kharatseius DA; Montsevichiute-Eringene EV
    Eksp Onkol; 1985; 7(5):45-7. PubMed ID: 4065019
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Co-operation between macrophages and a factor from lymphocytes in tumor lysis in vitro.
    Yamazaki M; Shinoda H; Mizuno D
    Gan; 1975 Oct; 66(5):489-97. PubMed ID: 1082827
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antigenic modification of mammalian cells undergoing 'spontaneous' malignant conversion.
    Kieler J
    Ser Haematol; 1972; 5(4):93-122. PubMed ID: 4133765
    [No Abstract]   [Full Text] [Related]  

  • 38. An assessment of intratumor phagocytic and surface marker-bearing cells in a series of autochthonous and early passaged chemically induced murine sarcomas.
    Pross HF; Kerbel RS
    J Natl Cancer Inst; 1976 Nov; 57(5):1157-67. PubMed ID: 1087351
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Macrophage and lymphocyte co-operation in target cell destruction in vitro.
    Zembala M; Ptak W; Hanczakowska M
    Clin Exp Immunol; 1973 Nov; 15(3):461-6. PubMed ID: 4357983
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Opsonization of tumor-reactive T cells in SJL/J mice bearing syngeneic tumors.
    Hutchinson IV; Bonavida B
    Cancer Immunol Immunother; 1982; 13(3):176-81. PubMed ID: 6984656
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.